DJIA 15,281.60 -12.90 -0.08%
NASDAQ 3,452.05 -7.37 -0.21%
S&P 500 1,646.24 -4.27 -0.26%

Amgen, Inc.

NASDAQ: AMGN

105.66 0.04 (0.04%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $105.74 0.11%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $105.10
Previous Close $105.62
Daily Range $104.37 - $106.03
52-Week Range $67.61 - $114.95
Market Cap $79.2B
P/E Ratio 17.84
Dividend (Yield) $1.88 (1.8%)
Ex-Dividend Date
Dividend Pay Date
05/14/13
06/07/13
Volume 1,297,492
Average Daily Volume 3,969,320
Current FY EPS $7.19

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Amgen Stock Checkup for May

How is one of the pioneers of biotech doing lately? Find out in this month's Amgen stock checkup.

Investing In Cancer Research Is Worth The Risk: Echo He

Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy

Amgen: Financial Analysis And Valuation

5 Stocks Raising The Drugs Industry Higher

A New Cancer-Killing Virus

Oncolytics announces successful tests for cancer drug Reolysin.

Can Financial Innovation Unlock a Cure for Cancer?

Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.

Stock Market News for May 22, 2013 - Market News

1 Biotech, 1 Financial And 1 Consumer Goods Company With Recent Intensive Insider Selling

UPDATE: Goldman Sachs Reiterates Buy Rating, $130 PT on Amgen Ahead of AMG 386 Phase 3 Data

See More AMGN News...

AMGN's Top Competitors

AMGN $105.66 (0.04%)
Current stock: AMGN
GILD $55.87 (0.70%)
Current stock: GILD
CELG $122.41 (-0.99%)
Current stock: CELG
$0.00 (0.00%)
Current stock: